Money Center Banks

April 24, 2014

Buy ($175)

Topics covered: Regulatory Outlook Gains Clarity, Opportunities in Larger Banks, Investing in Regional Banks, Investing in Financial Services, Interest Rates and Loan-Growth Strategies, Fed Capital Review Program, Challenging Revenue Environment

Companies covered: KeyCorp (NYSE:KEY), Zions Bancorporation (NASDAQ:ZION), PacWest Bancorp (NASDAQ:PACW), M&T Bank Corporation (NYSE:MTB), J P Morgan Chase & Co (NYSE:JPM), Hudson City Bancorp, Inc. (NASDAQ:HCBK), Goldman Sachs Group, Inc. (The) (NYSE:GS), Citigroup Inc. (NYSE:C), Bank of America Corporation (NYSE:BAC), Ohio Legacy Corp., Morgan Stanley (NYSE:MS), Discover Financial Services (NYSE:DFS), Capital One Financial Corporation (NYSE:COF)

Biotechnology and Pharmaceuticals

April 24, 2014

Buy ($175)

Topics covered: Orphan Drugs, Orphan Drug and Biologics Manufacturing, Oncology Drug Development, Health Care, Genetic and Cell Therapies, FDA Approval Process, Biotechnology and Pharmaceuticals, Biotechnology and Pharmaceutical Companies Valuation

Companies covered: MannKind Corporation (NASDAQ:MNKD), Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA), Oragenics, Inc. (AMEX:OGEN), Cempra, Inc. (NASDAQ:CEMP), Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Theravance, Inc. (NASDAQ:THRX), Pharmacyclics, Inc. (NASDAQ:PCYC), Merck & Company, Inc. (NYSE:MRK), InterMune Inc., Isis Pharmaceuticals, Inc. (NASDAQ:ISIS), Idenix Pharmaceuticals Inc., Gilead Sciences, Inc. (NASDAQ:GILD), Curis, Inc. (NASDAQ:CRIS), Cubist Pharmaceuticals Inc., Bristol-Myers Squibb Company (NYSE:BMY), Celgene Corporation (NASDAQ:CELG), NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX), Celladon Corporation (NASDAQ:CLDN), bluebird bio, Inc. (NASDAQ:BLUE), Amgen Inc. (NASDAQ:AMGN), Novartis AG (NYSE:NVS), Infinity Pharmaceuticals, Inc. (NASDAQ:INFI), Dendreon Corp., Novo Nordisk A/S (NYSE:NVO), GlaxoSmithKline PLC (NYSE:GSK)

Investing Strategies

April 23, 2014

Buy ($175)

Topics covered: Value Investment, Small-Cap Investing, Low-Volatility Investing, Long-Term Investing, Investment Risk Management Strategies, Investing in Agriculture, International Microcap Investing, High-Quality Companies

Companies covered: Comcast Corporation (NASDAQ:CMCSA), Apple Inc. (NASDAQ:AAPL), Amgen Inc. (NASDAQ:AMGN), Time Warner Cable Inc (NYSE:TWC), Home Depot, Inc. (The) (NYSE:HD), EMC Corporation (NYSE:EMC), Celgene Corporation (NASDAQ:CELG), Baidu, Inc. (NASDAQ:BIDU), Visa Inc. (NYSE:V), Under Armour, Inc. (NYSE:UA), Boston Beer Company, Inc. (The) (NYSE:SAM), Medtronic, Inc. (NYSE:MDT), Mastercard Incorporated (NYSE:MA), Johnson & Johnson (NYSE:JNJ), E-House (China) Holdings Limited (NYSE:EJ), Diageo plc (NYSE:DEO), Ctrip.com International, Ltd. (NASDAQ:CTRP), Citigroup Inc. (NYSE:C), Bank of America Corporation (NYSE:BAC), Aetna Inc. (NYSE:AET), Allianceberstein Holding L.P. (NYSE:AB), BioScrip, Inc. (NASDAQ:BIOS), Polaris Industries Inc. (NYSE:PII), Suncor Energy Inc. (NYSE:SU), Sun Life Financial Inc. (NYSE:SLF), Royal Bank Of Canada (NYSE:RY), Manulife Financial Corp (NYSE:MFC), Canadian Natural Resources Limited (NYSE:CNQ), Bank of Nova Scotia (The) (NYSE:BNS), Yum! Brands, Inc. (NYSE:YUM), Tyson Foods, Inc. (NYSE:TSN), Syngenta AG (NYSE:SYT), Sanderson Farms, Inc. (NASDAQ:SAFM), Potash Corporation of Saskatchewan Inc. (NYSE:POT), Mosaic Company (The) (NYSE:MOS), Monsanto Company (NYSE:MON), McDonald's Corporation (NYSE:MCD), Deere & Company (NYSE:DE), E.I. du Pont de Nemours and Company (NYSE:DD), CF Industries Holdings, Inc. (NYSE:CF), AGCO Corporation (NYSE:AGCO), Archer-Daniels-Midland Company (NYSE:ADM)

Latest News